18:25:10 EDT Thu 16 May 2024
Enter Symbol
or Name
USA
CA



Think Research Corp
Symbol THNK
Shares Issued 78,781,747
Close 2023-12-07 C$ 0.19
Market Cap C$ 14,968,532
Recent Sedar Documents

Think's Learning Management selected by pharma company

2023-12-07 17:42 ET - News Release

Mr. Sachin Aggarwal reports

THINK RESEARCH'S LEARNING MANAGEMENT SYSTEM TO SUPPORT HEALTHCARE PROFESSIONAL EDUCATION AND TRAINING

Think Research Corp. launched earlier this year a software-as-a-service-based Learning Management System that has been selected by a global pharmaceutical company as a bolt-on white-label education platform to support continually evolving pharmacist and physician on-line pharma education and training.

Sachin Aggarwal, chief executive officer of Think Research, stated: "Our Learning Management System continues to gain market momentum with a pharmaceutical client leveraging our technology to deliver essential education and training to clinicians who administer its solutions within health care delivery systems. Our data and software division continues to drive essential value for clinicians and healthcare delivery systems globally."

In addition to the LMS news, MDBriefCase, a Think Research company, and leading global provider of accredited on-line continuing medical education is leveraging expertise in oncology to expand education and training partnerships in the field, including new partnerships with the Canadian Association of Radiation Oncology (CARO) and Women in Cancer/All in Cancer (WinC-AlinC).

Additionally, MDBriefCase is extending its education and training expertise into new value-added specialty areas, expanding into the field of neurology through a new strategic partnership with the Canadian League Against Epilepsy (CLAE). As academic partners, MDBriefCase and CLAE are co-developing a series of educational modules addressing current challenges facing clinicians in the treatment and management of epilepsy, slated for launch in 2024.

About Think Research Corp.

Think Research is an industry leader in delivering knowledge-based digital health software solutions. The company's focused mission is to organize the world's health knowledge so everyone gets the best care. Its evidence-based health care technology solutions support the clinical decision-making process and standardize care to facilitate better health care outcomes. The company gathers, develops and delivers knowledge-based solutions globally to customers, which typically include enterprise clients, hospitals, health regions, health care professionals and/or governments. The company has gathered a significant amount of data by building its repository of knowledge through its network and group of companies, including acquired companies.

Think Research licenses its solutions to over 13,000 facilities for over 300,000 primary-care, acute-care and long-term-care doctors, nurses and pharmacists who rely on the content and data provided by Think Research to support their practices. Millions of patients and residents annually receive better care due to the essential data that Think Research produces, manages and delivers.

In addition, the company collects and manages pharmaceutical and clinical trial data through the BioPharma Services entity that Think Research acquired on Sept. 10, 2021. BioPharma Services is a leading provider of bioequivalence and phase 1 clinical research services to pharmaceutical companies globally. Think Research's other services include a network of digital-first primary-care clinics and medical clinics that provide elective surgery.

© 2024 Canjex Publishing Ltd. All rights reserved.